| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.78B | 34.29B | 32.73B | 31.28B | 29.45B | 26.83B |
| Gross Profit | 5.68B | 5.87B | 5.56B | 5.42B | 5.10B | 4.18B |
| EBITDA | 2.08B | 2.34B | 2.21B | 1.93B | 1.94B | 1.36B |
| Net Income | 1.03B | 1.03B | 906.00M | 832.00M | 599.00M | 208.00M |
Balance Sheet | ||||||
| Total Assets | 44.66B | 44.08B | 43.20B | 42.01B | 41.58B | 40.38B |
| Cash, Cash Equivalents and Short-Term Investments | 2.08B | 3.33B | 3.02B | 2.39B | 2.85B | 3.18B |
| Total Debt | 11.77B | 10.37B | 10.18B | 10.17B | 10.24B | 10.44B |
| Total Liabilities | 20.68B | 20.06B | 20.37B | 20.29B | 20.49B | 20.33B |
| Stockholders Equity | 23.98B | 24.02B | 22.83B | 21.71B | 21.08B | 20.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 226.00M | 525.00M | -209.00M | -109.00M | -116.00M |
| Operating Cash Flow | 0.00 | 1.13B | 1.37B | 583.00M | 887.00M | 764.00M |
| Investing Cash Flow | 0.00 | -697.00M | -462.00M | -617.00M | -1.00B | -968.00M |
| Financing Cash Flow | 0.00 | -132.00M | -283.00M | -390.00M | -221.00M | 363.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥856.79B | 8.44 | 10.78% | 4.68% | -1.97% | 47.63% | |
74 Outperform | ¥8.70B | 9.05 | ― | 3.97% | 0.34% | -1.55% | |
74 Outperform | ¥454.88B | 16.64 | 6.84% | 2.99% | -0.02% | -40.45% | |
71 Outperform | ¥211.59B | 19.04 | 5.06% | 1.80% | 4.10% | 152.90% | |
67 Neutral | ¥3.31T | -57.01 | -0.26% | 4.53% | 1.31% | -101.19% | |
64 Neutral | $1.22T | 24.61 | 2.92% | 4.59% | -8.07% | -41.42% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |